Belgium
· Delayed Price · Currency is EUR Biocartis Group NV Statistics
Total Valuation
Biocartis Group NV has a market cap or net worth of EUR 27.24 million. The enterprise value is 154.30 million.
| Market Cap | 27.24M |
| Enterprise Value | 154.30M |
Important Dates
The last earnings date was Friday, November 15, 2024.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Biocartis Group NV has 93.92 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 93.92M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +46.71% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 18.77% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.37 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.27 |
| EV / Sales | 2.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.01 |
Financial Position
The company has a current ratio of 2.15
| Current Ratio | 2.15 |
| Quick Ratio | 1.49 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.97 |
| Interest Coverage | -2.61 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -24.03% |
| Return on Capital (ROIC) | -28.59% |
| Revenue Per Employee | 115,631 |
| Profits Per Employee | -129,027 |
| Employee Count | 526 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 3.47 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.83% in the last 52 weeks. The beta is 1.33, so Biocartis Group NV's price volatility has been higher than the market average.
| Beta (5Y) | 1.33 |
| 52-Week Price Change | -77.83% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | 0.49 |
| Relative Strength Index (RSI) | 28.28 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biocartis Group NV had revenue of EUR 60.82 million and -67.87 million in losses. Loss per share was -0.87.
| Revenue | 60.82M |
| Gross Profit | -4.69M |
| Operating Income | -42.01M |
| Pretax Income | -68.04M |
| Net Income | -67.87M |
| EBITDA | -37.02M |
| EBIT | -42.01M |
| Loss Per Share | -0.87 |
Balance Sheet
The company has 25.18 million in cash and 152.25 million in debt, giving a net cash position of -127.07 million or -1.35 per share.
| Cash & Cash Equivalents | 25.18M |
| Total Debt | 152.25M |
| Net Cash | -127.07M |
| Net Cash Per Share | -1.35 |
| Equity (Book Value) | -53.99M |
| Book Value Per Share | -0.58 |
| Working Capital | 37.22M |
Cash Flow
In the last 12 months, operating cash flow was -49.96 million and capital expenditures -1.24 million, giving a free cash flow of -51.20 million.
| Operating Cash Flow | -49.96M |
| Capital Expenditures | -1.24M |
| Free Cash Flow | -51.20M |
| FCF Per Share | -0.55 |
Margins
Gross margin is -7.71%, with operating and profit margins of -69.06% and -111.58%.
| Gross Margin | -7.71% |
| Operating Margin | -69.06% |
| Pretax Margin | -111.86% |
| Profit Margin | -111.58% |
| EBITDA Margin | -60.86% |
| EBIT Margin | -69.06% |
| FCF Margin | -84.18% |
Dividends & Yields
Biocartis Group NV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -36.22% |
| Shareholder Yield | -36.22% |
| Earnings Yield | -298.55% |
| FCF Yield | -187.99% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Biocartis Group NV has an Altman Z-Score of -5.94. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.94 |
| Piotroski F-Score | n/a |